Application 062840
- Type
- ANDA
- Sponsor
- ACTAVIS MID ATLANTIC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NYSTATIN | NYSTATIN | OINTMENT;TOPICAL | 100,000 UNITS/GM | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062840-001 | NYSTATIN | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | 1987-11-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A062840-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A062840-001 | NYSTATIN | 100,000 UNITS/GM | OINTMENT / TOPICAL | AT | 1987-11-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A062840-001 | AT | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | Actavis Pharma, Inc. | aee7ce4c-8cc6-4446-a4d7-63bc4773066f | 2023-10-30 | Adverse reactions | 062840 ANDA062840 0472-0166 |
| Nystatin | NYSTATIN | Proficient Rx LP | d7d04c02-d07d-4382-8f93-5c0c3e68790c | 2022-10-01 | Adverse reactions | 062840 ANDA062840 63187-464 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0472-0166 | Nystatin | Nystatin | Actavis Pharma, Inc. | ANDA | Current |
| 0472-0166 | Nystatin | Nystatin | Actavis Pharma, Inc. | ANDA | Current |
| 53217-022 | Nystatin | Nystatin | Aidarex Pharmaceuticals LLC | ANDA | Current |
| 63187-464 | Nystatin | Nystatin | Proficient Rx LP | ANDA | Current |
| 63187-464 | Nystatin | Nystatin | Proficient Rx LP | ANDA | Current |
| 63187-464 | Nystatin | Nystatin | Proficient Rx LP | ANDA | Current |
| 63187-464 | Nystatin | Nystatin | Proficient Rx LP | ANDA | Current |